At the Detroit Free Press Breakfast Club Series on Tuesday, automotive leaders Mark Reuss, of General Motors, and Roger Penske, a racing executive and business man, discussed the automotive industry.

The Chicago Bears, led by former Lions offensive coordinator Ben Johnson, have become a Super Bowl contender by adopting Detroit's previous winning formula. Chicago's success is built on a strong ...

Plain and simple, the Detroit Lions are not as good as they were a season ago. They're also not remotely close to as good as they were when they nearly advanced to the Super Bowl during the 2023 ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

In the vibrant landscape of Detroit, one name stands out as a champion for culture and community: Dave Bishop. As the driving force behind the DET AWARDS WEEKEND, Bishop embodies the role of a curator ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Ahead of Cyber Monday, a small business in Grosse Pointe, Michigan, is reminding shoppers of the perks of buying small. "We are going on 67 years, and I started working when I was 12," said Antionette ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

The march down Woodward Avenue, which endured through the city’s hardest years, features papier-mâché caricatures that are uniquely Detroit. The march down Woodward Avenue, which endured through the ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...